According to the latest study from BCC Research, "Global Cell Line and Membrane Market" is estimated to increase from $6.3 billion in 2025 to reach $11.4 billion by the end of 2030, at a compound ...

Novel allogeneic stem cells and differentiated iPSCs are providing more physiologically relevant disease models.

Researchers identified that triterpene glycosides from the starfish Solaster pacificus can kill drug-resistant prostate ...

Pig Assay Joins Industry-Leading Catalog, Supporting Translational and Comparative Research ...

We learn more about the CellCelector, its applications, how it overcomes the limitations of other instruments and top tips ...

In this webinar, Kevin Grady and Manisha Nautiyal will outline how to make predictive 3D cell models for therapeutic ...

One of the main factors determining therapeutic antibodies’ half-life is the interaction between the antibody’s Fc region and ...

Trailhead Biosystems, Inc. (TrailBio.com), a biotechnology company advancing scalable human cell models derived from induced pluripotent stem cells (iPSCs), announces the commercial release of ...

The Cell Culture Market presents strong growth opportunities, especially in regions like North America and Asia-Pacific where biopharmaceutical R&D ...

Patients must express PPARG in at least 60 percent of tumor cells to enroll in the trial and receive the investigational drug.

Pluristyx, a leading provider of induced pluripotent stem cell (iPSC) technologies and proprietary gene editing solutions, today announced the successful close of its most recent round of funding led ...